Impact of sarA on Daptomycin Susceptibility of Staphylococcus aureus Biofilms In Vivo
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
We used a murine model of catheter-associated biofilm formation to determine whether the mutation of the staphylococcal accessory regulator ( sarA ) has an impact on the susceptibility of established Staphylococcus aureus biofilms to treatment with daptomycin in vivo. The experiments were done with two clinical isolates, one of which (UAMS-1) was obtained from the bone of a patient suffering from osteomyelitis, while the other (UAMS-1625) is an isolate of the USA300 clonal lineage of community-acquired methicillin (meticillin)-resistant S. aureus . UAMS-1625 had a reduced capacity to form a biofilm in vivo compared to that of UAMS-1 ( P = 0.0015), but in both cases the mutation of sarA limited biofilm formation compared to that of the corresponding parent strain ( P ≤ 0.001). The mutation of sarA did not affect the daptomycin MIC for either strain, but it did result in increased susceptibility in vivo in the context of an established biofilm. Specifically, daptomycin treatment resulted in the clearance of detectable bacteria from <10% of the catheters colonized with the parent strains, while treatment with an equivalent daptomycin concentration resulted in the clearance of 46.4% of the catheters colonized with the UAMS-1 sarA mutant and 69.1% of the catheters colonized with the UAMS-1625 sarA mutant. In the absence of daptomycin treatment, mice with catheters colonized with the UAMS-1625 parent strain also developed skin lesions in the region adjacent to the implanted catheter. No such lesions were observed in any other experimental group, including untreated mice containing catheters colonized with the UAMS-1625 sarA mutant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, R., Braughton, K. R., Kretschmer, D., Bach, T.-H. L., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J., Peschel, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1656 · Cited by 1,046 · cited 1×
“The reasons for such strain-dependent differences have not been clearly defined (5, 16, 24, 40, 41, 43).”
BackgroundSarA and not σB is essential for biofilm development by Staphylococcus aureus
Valle, J., Toledo‐Arana, A., Berasain, C., Ghigo, J., Amorena, B., Penadés, J. R., & Lasa, I. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03493.x · Cited by 442
Wardenburg, J. B., Palazzolo‐Ballance, A. M., Otto, M., Schneewind, O., & DeLeo, F. R. (2008) · The Journal of Infectious Diseases · doi:10.1086/592053 · Cited by 236 · cited 1×
“In this respect it is interesting that the mutation of sarA in UAMS-1625 resulted in the reduced production of alpha toxin, which has been proposed as the primary virulence determinant of USA300 clonal isolates (7).”
Background
Cited by
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
From in vitro to in vivo Models of Bacterial Biofilm-Related Infections
Lebeaux, D., Chauhan, A., Rendueles, O., & Beloin, C. (2013) · Pathogens · doi:10.3390/pathogens2020288 · Cited by 545
New approaches for treating staphylococcal biofilm infections
Kiedrowski, M. R., & Horswill, A. R. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06281.x · Cited by 288
Yadav, M. K., Chae, S.-W., Im, G. J., Chung, J.-W., & Song, J.-J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119564 · Cited by 258
Mrak, L. N., Zielinska, A. K., Beenken, K. E., Mrak, I. N., Atwood, D. N., Griffin, L. M., Lee, C. Y., & Smeltzer, M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038453 · Cited by 89
Self-citation
Metadata
- Authors
- Weiss, E. C., Zielinska, A., Beenken, K. E., Spencer, H. J., Daily, S. J., & Smeltzer, M. S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-10
- Volume
- 53
- Issue
- 10
- Pages
- 4096-4102
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2159979739
- Cited by
- 72
- References
- 3
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.